Details for New Drug Application (NDA): 050551
✉ Email this page to a colleague
The generic ingredient in CEFOBID is cefoperazone sodium. There are four drug master file entries for this compound. Additional details are available on the cefoperazone sodium profile page.
Summary for 050551
Tradename: | CEFOBID |
Applicant: | Pfizer |
Ingredient: | cefoperazone sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 050551
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
Approval Date: | Nov 18, 1982 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
Approval Date: | Nov 18, 1982 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10GM BASE/VIAL | ||||
Approval Date: | Mar 5, 1990 | TE: | RLD: | No |
Complete Access Available with Subscription